Annals of Oncology Advance Access originally published online on September 12, 2006
Annals of Oncology 2006 17(11):1698-1704; doi:10.1093/annonc/mdl183
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2006 European Society for Medical Oncology
quality of life and supportive care |
Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975
1 European Organisation for Research and Treatment of Cancer (EORTC), EORTC Data Center, Brussels, Belgium
2 Vrije Universiteit Medical Center, Amsterdam, The Netherlands
3 Hospital de Mataro, Spain
4 St. Antonius Hospital, Nieuwegein, The Netherlands
5 Rijnstate Hospital Arnhem, The Netherlands
6 National Cancer Institute, Cairo, Egypt
7 Jeroen Bosch Ziekenhuis's-Hertogenbosch, The Netherlands
8 University Medical Center, Mannheim, Germany
9 University Hospital, Ghent, Belgium
*Correspondence to: Dr F. Efficace, European Organization for Research and Treatment of Cancer (EORTC), Quality of Life Unit, Avenue E. Mounier, 83, 1200 Brussels, Belgium. Tel: +32 2 7741680; Fax: +32 2 7794568; E-mail: f.efficace{at}fondazioneime.org
Background: The aim of this prognostic factor analysis was to investigate if a patient's self-reported health-related quality of life (HRQOL) provided independent prognostic information for survival in non-small cell lung cancer (NSCLC) patients.
Patients and methods: Pretreatment HRQOL was measured in 391 advanced NSCLC patients using the EORTC QLQ-C30 and the EORTC Lung Cancer module (QLQ-LC13). The Cox proportional hazards regression model was used for both univariate and multivariate analyses of survival. In addition, a bootstrap validation technique was used to assess the stability of the outcomes.
Results: The final multivariate Cox regression model retained four parameters as independent prognostic factors for survival: male gender with a hazard ratio (HR) = 1.32 (95% CI 1.031.69; P = 0.03); performance status (0 to 1 versus 2) with HR = 1.63 (95% CI 1.042.54; P = 0.032); patient's self-reported score of pain with HR= 1.11 (95% CI 1.071.16; P < 0.001) and dysphagia with HR = 1.12 (95% CI 1.041.21; P = 0.003). A 10-point shift worse in the scale measuring pain and dysphagia translated into an 11% and 12% increased in the likelihood of death respectively. A risk group categorization was also developed.
Conclusion: The results suggest that patients' self-reported HRQOL provide independent prognostic information for survival. This finding supports the collection of such data in routine clinical practice.
Key words: lung cancer, prognostic factor, quality of life, survival
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
E. Basch, X. Jia, G. Heller, A. Barz, L. Sit, M. Fruscione, M. Appawu, A. Iasonos, T. Atkinson, S. Goldfarb, et al. Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes J Natl Cancer Inst, December 2, 2009; 101(23): 1624 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Movsas, J. Moughan, L. Sarna, C. Langer, M. Werner-Wasik, N. Nicolaou, R. Komaki, M. Machtay, T. Wasserman, and D. W. Bruner Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non-Small-Cell Lung Cancer: An Analysis of RTOG 9801 J. Clin. Oncol., December 1, 2009; 27(34): 5816 - 5822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. G. Blanco, I. S. Toste, R. F. Alvarez, G. R. Cuadrado, A. M. Gonzalvez, and I. J. G. Martin Age, comorbidity, treatment decision and prognosis in lung cancer Age Ageing, November 1, 2008; 37(6): 715 - 718. [Full Text] [PDF] |
||||
![]() |
F. Efficace, P. F. Innominato, G. Bjarnason, C. Coens, Y. Humblet, S. Tumolo, D. Genet, M. Tampellini, A. Bottomley, C. Garufi, et al. Validation of Patient's Self-Reported Social Functioning As an Independent Prognostic Factor for Survival in Metastatic Colorectal Cancer Patients: Results of an International Study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer J. Clin. Oncol., April 20, 2008; 26(12): 2020 - 2026. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Gotay, C. T. Kawamoto, A. Bottomley, and F. Efficace The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials J. Clin. Oncol., March 10, 2008; 26(8): 1355 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Jones and C. C. Doebbeling Beyond the Traditional Prognostic Indicators: The Impact of Primary Care Utilization on Cancer Survival J. Clin. Oncol., December 20, 2007; 25(36): 5793 - 5799. [Abstract] [Full Text] [PDF] |
||||


